Clinical laboratory · 2026
Mixed Phenotype Acute Leukemia with B/T Lineage and BCR-ABL1 Rearrangement: a Case Report and Literature Review.
СтатьяКлинический случайОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mamad Hassane, Siyar Hamza, Zirar Jalila, Regragui Ismail, Benkirane Souad, Masrar Azlarab
Аннотация
BACKGROUND: We report a case of B/T mixed phenotype acute leukemia (MPAL) with BCR-ABL1 rearrangement in a 35-year-old male presenting with hemorrhage, infection, and hemodynamic instability.
METHODS: Laboratory findings showed bicytopenia (hemoglobin 79 g/L, platelets 17 x 10⁹/L), leukocytosis (7.7 x 10⁹/L). Peripheral blood and bone marrow smears showed 22% and 66% myeloperoxidase-negative blasts, respectively. Immunophenotyping identified coexisting T-lineage (cytoplasmic CD3+, CD2+, CD5+) and B-lineage (CD19+, CD79a+, cytoplasmic IgM+) populations. Fluorescence in situ hybridization confirmed BCR-ABL1.
RESULTS: The diagnosis for our case was B/T MPAL with BCR-ABL1 rearrangement. The patient achieved com-plete remission with tyrosine kinase inhibitors per GRALL-2014 protocol and is awaiting matched sibling donor transplantation.
CONCLUSIONS: This case demonstrates the diagnostic complexity and aggressive nature of BCR-ABL1-positive B/T MPAL.
METHODS: Laboratory findings showed bicytopenia (hemoglobin 79 g/L, platelets 17 x 10⁹/L), leukocytosis (7.7 x 10⁹/L). Peripheral blood and bone marrow smears showed 22% and 66% myeloperoxidase-negative blasts, respectively. Immunophenotyping identified coexisting T-lineage (cytoplasmic CD3+, CD2+, CD5+) and B-lineage (CD19+, CD79a+, cytoplasmic IgM+) populations. Fluorescence in situ hybridization confirmed BCR-ABL1.
RESULTS: The diagnosis for our case was B/T MPAL with BCR-ABL1 rearrangement. The patient achieved com-plete remission with tyrosine kinase inhibitors per GRALL-2014 protocol and is awaiting matched sibling donor transplantation.
CONCLUSIONS: This case demonstrates the diagnostic complexity and aggressive nature of BCR-ABL1-positive B/T MPAL.